معرفی
Prof. Dr. Siavosh Mahboobi is a faculty member at the University of Regensburg, affiliated with the Institute of Pharmacy and working in the Pharmaceutical/Medicinal Chemistry I department. His research focuses on molecular mechanisms of cancer and the development of targeted therapies.
- Signal transduction pathways in cancer
- FLT3 and PDGFR tyrosine kinase inhibitors
- HDAC and tubulin inhibition strategies
- EGFR-targeted therapies
- 5-HT receptor agonists/antagonists
His work emphasizes the design of small molecules that disrupt cancer-related signaling. He has received the PHOENIX Pharmaceutical Sciences Award (2011) for his contributions to anticancer drug development.
۰مقاله منتشرشده
